Search

everythinglearnresearchcommunity

for

Search:↓

Injecting platelet-derived growth factors into ovaries may improve IVF outcomes by enhancing egg quality and embryo health.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Deslorelin effectively treats hair loss in neutered ferrets by reducing hormone levels.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

PSA can help diagnose high androgen levels in women.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

COVID-19 may harm male fertility and damage the reproductive system.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.